EvoNext net loss widens to CHF 0.6 million in first half 2026
Bitget2026/09/30 05:01- EvoNext posted a net loss of CHF 0.6 million for the first six months.
- Liquidity totaled CHF 5.5 million, including CHF 4.2 million cash and CHF 1.3 million liquid securities.
- Total assets stood at CHF 5.6 million, while equity was CHF 5.3 million as of June 30, 2026.
- The net loss was mainly driven by transaction- and search-related one-off expenses.
- Board continued exploring reverse takeovers, while talks with Ascend Sport Technology envisioned CHF 2.50 per-share valuation for shareholders.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Starbucks (SBUX.US) officially refutes rumors: clearly denies acquiring Chipotle (CMG.US), focuses on "Back to Starbucks" transformation strategy
Starbucks publicly clarified on Monday that the company has not acquired Chipotle Mexican Grill, putting an end to the previous acquisition rumors.
BlackRock increases allocation to short-term US Treasuries and lowers US stocks: "Rate hike bets have gone too far," high yields should be prioritized
BlackRock has turned bullish on U.S. Treasury bonds for the first time in six years, upgrading short-term bonds to overweight and downgrading U.S. equities to neutral, stating that rate hike expectations are excessive and it is time to lock in yields.
AstraZeneca (AZN.US) Relizumab's new indication is expected to be included in priority review
Relizumab is a blockbuster product under AstraZeneca, with global sales projected to reach 4.718 billions USD in 2025 (YOY +20.23%).
4 Big Bank Earnings to Watch This Week as Wall Street Turns Bullish
Crypto prices
More
